Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.35 CHF | -.--% |
|
-.--% | -.--% |
May. 09 | DA Davidson Adjusts Nu Skin Enterprises' Price Target to $12.50 From $15.50, Keeps Neutral Rating | MT |
May. 08 | Transcript : Nu Skin Enterprises, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Sales 2024 * | 1.77B 1.59B | Sales 2025 * | 1.83B 1.64B | Capitalization | 523M 470M |
---|---|---|---|---|---|
Net income 2024 * | 45M 40.42M | Net income 2025 * | 70M 62.88M | EV / Sales 2024 * | 0.4 x |
Net Debt 2024 * | 192M 172M | Net Debt 2025 * | 96.6M 86.78M | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
11.6
x | P/E ratio 2025 * |
7.37
x | Employees | - |
Yield 2024 * |
2.28% | Yield 2025 * |
2.28% | Free-Float | 53.65% |
Latest transcript on Nu Skin Enterprises, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Ryan Napierski
CEO | Chief Executive Officer | 50 | 15-09-07 |
Founder | 67 | 83-12-31 | |
Steven Lund
FOU | Founder | 70 | 83-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Lund
FOU | Founder | 70 | 83-12-31 |
Founder | 67 | 83-12-31 | |
Thomas Pisano
BRD | Director/Board Member | 79 | 08-05-31 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.54% | 389B | |
+14.34% | 137B | |
+21.74% | 79.62B | |
-7.06% | 69.77B | |
-27.25% | 38.15B | |
-15.56% | 34.81B | |
+0.63% | 32.75B | |
+8.56% | 17.97B | |
+21.63% | 16.88B |
- Stock Market
- Equities
- NUS Stock
- NUS Stock